Pharmalogic ApS: Financial statements 2023
CVR: 42323519
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmalogic ApS (CVR 42323519) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 14,960,830 and a net result of DKK 1,293,878 compared with DKK 578,397 the year before. That is an increase of 102.3% compared with the year before. Equity in the 2023 report amounted to DKK 1,935,942. The solvency ratio was 41.1%. The company had 11 employees in the financial year.
- Gross Profit
- DKK 14,960,830
- Profit/Loss
- DKK 1,293,878
- Equity
- DKK 1,935,942
- Total Assets
- DKK 4,714,671
- Employees
- 11
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 15 mio. | 1.3 mio. | 1.9 mio. | 11 |
| 2022 | - | 7.4 mio. | 578 t. | 1.1 mio. | 7 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmalogic ApS has published its annual report for 2022. Gross profit came to DKK 7,396,258, and the net result was DKK 578,397.
About Pharmalogic ApS
Pharmalogic ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2021. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Tanja Dybdal Beck and Allan Christian Beck. The company is owned by DYBDAL BECK INVEST ApS. According to the 2025 annual report, the company had an average of 23 employees. In 2025, the company reported a gross profit of DKK 25,106,323 and a net result of DKK 1,079,238 compared with DKK -693,511 the year before. Equity in the 2025 report amounted to DKK 1,340,263.